SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long term, according to a study from the UK and Ireland.

The team, led by Hye Sun Gwak, analyzed data from 13 studies and found that several types of blood pressure medications—ACE ...

Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Red light therapy is increasingly viewed as a promising treatment for wrinkles, acne, psoriasis, scars and sun-damaged skin, and as a supportive therapy for some kinds of cancer. But does red light ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Red light therapy is an emerging treatment for various skin conditions and some types of cancer. It stimulates cellular activity and aids healing, similar to a body's response to a wound. Despite its ...